Charles Schwab’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Charles Schwab’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-285,058	Closed	-$10.7M	–	3630
2021 Q1	$10.7M	Sell	285,058 -30,417	-10%	-$1.15M	﹤0.01%	1921
2020 Q4	$5.37M	Buy	315,475 +31,716	+11%	+$540K	﹤0.01%	2183
2020 Q3	$1.33M	Buy	283,759 +70,133	+33%	+$330K	﹤0.01%	2613
2020 Q2	$1.3M	Sell	213,626 -1,289	-0.6%	-$7.87K	﹤0.01%	2555
2020 Q1	$488K	Buy	214,915 +3,061	+1%	+$6.95K	﹤0.01%	2722
2019 Q4	$973K	Sell	211,854 -5,992	-3%	-$27.5K	﹤0.01%	2603
2019 Q3	$845K	Buy	217,846 +31,894	+17%	+$124K	﹤0.01%	2618
2019 Q2	$1.12M	Sell	185,952 -18,015	-9%	-$109K	﹤0.01%	2542
2019 Q1	$2.73M	Buy	203,967 +15,543	+8%	+$208K	﹤0.01%	2252
2018 Q4	$1.75M	Sell	188,424 -2,131	-1%	-$19.8K	﹤0.01%	2377
2018 Q3	$2.65M	Buy	190,555 +14,660	+8%	+$204K	﹤0.01%	2341
2018 Q2	$2.78M	Buy	175,895 +22,572	+15%	+$357K	﹤0.01%	2268
2018 Q1	$2.64M	Buy	153,323 +23,616	+18%	+$406K	﹤0.01%	2222
2017 Q4	$2.84M	Sell	129,707 -11,044	-8%	-$242K	﹤0.01%	2176
2017 Q3	$5.76M	Buy	140,751 +28,954	+26%	+$1.18M	0.01%	1804
2017 Q2	$3.37M	Sell	111,797 -10,743	-9%	-$324K	﹤0.01%	2015
2017 Q1	$4.43M	Sell	122,540 -83,016	-40%	-$3M	﹤0.01%	1828
2016 Q4	$10.3M	Sell	205,556 -12,322	-6%	-$617K	0.01%	1233
2016 Q3	$11.4M	Buy	217,878 +73,886	+51%	+$3.88M	0.01%	1067
2016 Q2	$5.96M	Buy	143,992 +98,353	+216%	+$4.07M	0.01%	1455
2016 Q1	$1.86M	Buy	45,639 +3,139	+7%	+$128K	﹤0.01%	2088
2015 Q4	$1.76M	Buy	42,500 +9,200	+28%	+$382K	﹤0.01%	2144
2015 Q3	$513K	Hold	33,300	–	–	﹤0.01%	2615
2015 Q2	$828K	Hold	33,300	–	–	﹤0.01%	2501
2015 Q1	$761K	Buy	33,300 +8,000	+32%	+$183K	﹤0.01%	2474
2014 Q4	$684K	Hold	25,300	–	–	﹤0.01%	2510
2014 Q3	$297K	Hold	25,300	–	–	﹤0.01%	2802
2014 Q2	$394K	Buy	+25,300	New	+$394K	﹤0.01%	2735